These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 21739990)
1. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990 [TBL] [Abstract][Full Text] [Related]
2. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Jiang G; Park K; Kim J; Kim KS; Hahn SK Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144 [TBL] [Abstract][Full Text] [Related]
3. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451 [TBL] [Abstract][Full Text] [Related]
4. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Park K; Lee MY; Kim KS; Hahn SK Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932 [TBL] [Abstract][Full Text] [Related]
6. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing. Park K; Yang JA; Lee MY; Lee H; Hahn SK Bioconjug Chem; 2013 Jul; 24(7):1201-9. PubMed ID: 23731084 [TBL] [Abstract][Full Text] [Related]
7. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832 [TBL] [Abstract][Full Text] [Related]
8. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis. Lee H; Kim IK; Park TG Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095 [TBL] [Abstract][Full Text] [Related]
9. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications. Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511 [TBL] [Abstract][Full Text] [Related]
10. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409 [TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Kim SH; Mok H; Jeong JH; Kim SW; Park TG Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275 [TBL] [Abstract][Full Text] [Related]
14. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. Lee H; Mok H; Lee S; Oh YK; Park TG J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798 [TBL] [Abstract][Full Text] [Related]
15. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
16. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery. Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799 [TBL] [Abstract][Full Text] [Related]
18. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Wang J; Dou B; Bao Y Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238 [TBL] [Abstract][Full Text] [Related]
19. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Zintchenko A; Philipp A; Dehshahri A; Wagner E Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894 [TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]